Broker Newswire
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
SUBSCRIBE
No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Online Trading
    • Cryptocurrencies
    • Stocks
  • Markets
    • Earnings
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Saving money
    • Retirement
  • Economy
  • Tech
    • Enterprise
    • Internet
No Result
View All Result
Broker Newswire
No Result
View All Result
Home Latest News General

Stimwave Spinal Cord Stimulators Awarded US Government DAPA Contract

by Jay Helton
April 22, 2017
1 min read
0
stimwave dapa contract
Share on FacebookShare on Twitter

On April the 21st, Stimwave LLC, which is primarily known for manufacturing medical devices, announced it had been awarded a DAPA, Distribution and Pricing Agreement, from the Defense Logistic Agency. The company manufactures several stimulation systems including the StimQ Peripheral Nerve Stimulator and the Freedom Spinal Cord Stimulation System. The company has now received a five-year contract with the US governmental agency. The contract, which was negotiated by TAMM Net Inc., is the first involving spinal cord stimulators and a United States government agency.

Stimwave’s devices rely on an exclusive Wireless Pain Relief technology to deliver small pulses of energy directly to the nerves in the body. In return, the sensation triggers the brain and forces a remapping of the pain pathways leading directly to pain relief. Stimwave devices tend to be 95% smaller than alternative neuromodulation devices on the market. During use, the device will be affixed to an anchor, so it can remain parallel with the body’s nerves. Thanks to the positioning and size of Stimwave’s device, it provides the user with more freedom of motion than the bulkier implanted devices.

The devices, which have been cleared by the FDA for treatment of chronic back and leg pain, were released to a limited number of patients during 2015. Simultaneously, the FDA granted Stimwave an FDA 510 (k) for the relief of peripheral nervous system pain. Stimwave is the only neuromodulation device manufacturer to receive FDA clearance for the relief of chronic neuropathic pain for most locations around the body. To learn more about Stimwave’s wireless stimulator system, be sure to visit their official website at www.stimwave.com.

RELATED STORIES

Volkswagen must pay damages

Volkswagen must pay damages to buyers of manipulated diesel cars

May 25, 2020
Future Cloud Banking and Fintech

Future Cloud Predictions for Banking and Fintech Sector

April 23, 2020
Tags: fdastimwave
Create your Web Presence with Namecheap

Recent Posts

  • Bitcoin and crypto spending is allowed by PayPal Now
  • The event in the live stream: Apple releases 5G-capable iPhone – Business
  • Volkswagen thriller: An unpopular supplier, audio recordings and a dead man
  • Tencent and WeChat also affected: Why Trump’s TikTok ban could harm Silicon Valley
  • Hacker attack on Twitter: “Group of young people” is supposed to be behind the attack on the social media platform

Category

  • Acquisitions
  • Broker Related
  • Earnings Reports
  • Economy
  • Enterprise
  • General
  • Internet
  • Investing
  • IPO News
  • Latest News
  • Layoffs
  • Markets
  • Online Trading
  • Opinion
  • OTC Markets
  • Penny Stocks
  • Personal Finance
  • Retirement
  • Saving money
  • Stocks
  • Technology

About Us

Broker Newswire (BN) is an exciting new online publication, which targets finances, brokers, mortgage and markets. BN, which is the nation’s leading provider of real estate, finance and market news and analysis.

  • About
  • Advertise
  • Privacy & Policy
  • Feedback

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Latest News
  • Investing
    • Acquisitions
    • Broker Related
    • Cryptocurrencies
    • Online Trading
    • Stocks
  • Markets
    • Earnings Reports
    • OTC Markets
    • Penny Stocks
  • Personal Finance
    • Retirement
    • Saving money
  • Economy
  • Tech
    • Enterprise
    • Internet
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.